Literature DB >> 9355742

Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58.

M P Chadwick1, B R Westley, F E May.   

Abstract

The single-domain human trefoil proteins [pNR-2/pS2 and human intestinal trefoil factor (hITF)] have seven cysteine residues, of which six are involved in maintaining the structure of the trefoil domain. The seventh does not form part of the trefoil domain and is located three residues from the C-terminus. The ability of the pNR-2/pS2 single trefoil domain protein to dimerize was examined by using recombinant protein with either a cysteine or a serine residue at this position by equilibrium ultracentrifugation, laser-assisted desorption MS, gel filtration and PAGE. pNR-2/pS2 Cys58 formed dimers, whereas pNR-2/pS2 Ser58 did not. Experiments in which the dimer was treated with thiol agents demonstrated that the dimer was linked via a disulphide bond and that the intermolecular disulphide bond was more susceptible to reduction than the intramolecular disulphide bonds. To examine whether dimeric pNR-2/pS2 was secreted by oestrogen-responsive breast cancer cells, which are known to express pNR-2/pS2 mRNA, conditioned medium was separated on non-denaturing polyacrylamide gels, transferred to PVDF membrane and reacted with antiserum against pNR-2/pS2. Monomeric and dimeric pNR-2/pS2 were detected but the majority of the protein reactivity was associated with a larger protein. Treatment of this protein with thiol agents suggested that it is an oligomer containing pNR-2/pS2 linked to another protein by a disulphide bond. These studies suggest that the biological action of pNR-2/pS2 single-domain trefoil protein might involve the formation of homodimers or oligomers with other proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355742      PMCID: PMC1218770          DOI: 10.1042/bj3270117

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis. Polydispersity and genetic polymorphism.

Authors:  F Hauser; W Hoffmann
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

2.  Identification and characterization of estrogen-regulated RNAs in human breast cancer cells.

Authors:  F E May; B R Westley
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

3.  High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein.

Authors:  V I Polshakov; M A Williams; A R Gargaro; T A Frenkiel; B R Westley; M P Chadwick; F E May; J Feeney
Journal:  J Mol Biol       Date:  1997-03-28       Impact factor: 5.469

4.  Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry.

Authors:  N H Piggott; J A Henry; F E May; B R Westley
Journal:  J Pathol       Date:  1991-02       Impact factor: 7.996

5.  Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.

Authors:  J A Foekens; W L van Putten; H Portengen; H Y de Koning; B Thirion; J Alexieva-Figusch; J G Klijn
Journal:  J Clin Oncol       Date:  1993-05       Impact factor: 44.544

6.  Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues.

Authors:  N A Wright; R Poulsom; G W Stamp; P A Hall; R E Jeffery; J M Longcroft; M C Rio; C Tomasetto; P Chambon
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

7.  pS2 expression and response to hormonal therapy in patients with advanced breast cancer.

Authors:  L H Schwartz; F C Koerner; S M Edgerton; J M Sawicka; M C Rio; J P Bellocq; P Chambon; A D Thor
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

8.  Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk.

Authors:  C Tomasetto; C Wolf; M C Rio; M Mehtali; M LeMeur; P Gerlinger; P Chambon; R Lathe
Journal:  Mol Endocrinol       Date:  1989-10

9.  Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.

Authors:  J A Henry; M K Bennett; N H Piggott; D L Levett; F E May; B R Westley
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

10.  pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.

Authors:  J A Henry; N H Piggott; U K Mallick; S Nicholson; J R Farndon; B R Westley; F E May
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  23 in total

1.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

Authors:  J I Semple; J L Newton; B R Westley; F E May
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

3.  Interaction of trefoil family factors with mucins: clues to their mechanism of action?

Authors:  N A Wright
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

Review 4.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

Review 5.  Trefoils: An unexplored natural protective shield of oral cavity.

Authors:  Akanksha Choudhary; C N Smitha; D K Suresh
Journal:  J Oral Biol Craniofac Res       Date:  2015-07-29

6.  Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.

Authors:  Somchai Chutipongtanate; Yasushi Nakagawa; Suchai Sritippayawan; Jeeraporn Pittayamateekul; Paisal Parichatikanond; Bruce R Westley; Felicity E B May; Prida Malasit; Visith Thongboonkerd
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 7.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

8.  Molecular forms of trefoil factor 1 in normal gastric mucosa and its expression in normal and abnormal gastric tissues.

Authors:  Jian-Lin Ren; Jin-Yan Luo; Ya-Pi Lu; Lin Wang; Hua-Xiu Shi
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

9.  Relationship between trefoil factor 1 expression and gastric mucosa injuries and gastric cancer.

Authors:  Jian-Lin Ren; Jin-Yan Luo; Ya-Pi Lu; Lin Wang; Hua-Xiu Shi
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

10.  The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach.

Authors:  F E May; J I Semple; J L Newton; B R Westley
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.